ArticleFrontiers in medicine2025
Acute multisystemic thromboembolism manifesting as cerebral infarction, myocardial injury, and quadriparesis: a novel triad of idiopathic hypereosinophilic syndrome.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypersegmented Eosinophil Syndrome (HES) is a rare myeloproliferative condition with several clinical symptoms. Idiopathic HES presenting with acute, contemporaneous multisystem thrombotic episodes is extremely unusual, making clinical detection difficult and increasing the risk of misdiagnosis. Case presentation: This paper describes the case of a 69-years-old male patient with a history of coronary heart disease and hypertension, who was admitted for "dizziness accompanied by discomfort in the left shoulder and precordial region." The patient was initially diagnosed with posterior circulation ischemia, but quickly developed a clinical trial of acute cerebral infarction (confirmed by cranial MRI), non-ST-segment elevation myocardial infarction (confirmed by progressively rising cardiac markers and ECG), and acute quadriplegia (muscle strength 0-3). Laboratory tests revealed significant peripheral blood eosinophilia (43.4%). Coronary CT scans ruled out acute in-stent restenosis. Bone marrow aspiration and genetic testing ruled out other clonal anomalies, resulting in a diagnosis of "idiopathic hypereosinophilic syndrome." Discussion: This case report describes a novel clinical situation in which an acute thromboembolic triad (cerebral infarction, cardiac damage, and quadriplegia) is the first presentation of idiopathic HES. It demonstrates that eosinophil-mediated hypercoagulability is the primary pathogenic mechanism behind multisystem embolism. Conclusion: Prompt blood tests to assess eosinophil counts remain critical for early identification of HES, especially in the absence of usual clinical history. Early and strong glucocorticoid treatment efficiently reduces eosinophil levels and improves prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.